FDA OKs Trifarotene, First New Retinol Acne Cream in 20 Years – Medscape
The US Food and Drug Administration (FDA) has approved trifarotene cream 0.005% (Aklief, Galderma), the first new retinoid molecule to be approved in the United States in over 20 years for the once-daily topical treatment of acne vulgaris, according to a company news release. Trifarotene is the only topical retinoid that selectively targets retinoic acid… Read More »